Leishmania donovani: amastigote inhibition and mode of action of berberine.
Berberine, an alkaloid from Berberis aristata Linnaeus, may be a useful drug for the treatment of visceral leishmaniasis. In both the 8-day and long-term models of Leishmania donovani infection in hamsters, it markedly diminished the parasitic load and proved to be less toxic than pentamidine. It rapidly improved the hematological picture of infected animals. Like pentamidine, it inhibited in vitro multiplication of amastigotes in macrophage culture and their transformation to promastigotes in cell free culture. Manometric studies showed that both drugs had inhibitory action on both the endogenous and the glucose-stimulated respiration of amastigotes. They inhibited incorporation of [14C]adenine, [14C]uracil, and [3H]thymidine into nucleic acids, and of [14C]leucine into the protein of amastigotes, indicating an inhibitory action on macromolecular biosynthesis. They also decreased deoxyglucose uptake. Using spectrophotometric, spectrofluorimetric, and circular dichroism techniques, berberine was found to interact in vitro with nuclear DNA from L. donovani promastigotes.
D000818:Animals; D001599:Berberine / Q000378:metabolism / Q000627:therapeutic use*; D001600:Berberine Alkaloids / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D006224:Cricetinae; D004247:DNA / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D004906:Erythrocyte Count; D007893:Leishmania donovani / Q000187:drug effects / Q000254:growth & development; D007898:Leishmaniasis, Visceral / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D007958:Leukocyte Count; D008099:Liver / Q000469:parasitology; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010419:Pentamidine / Q000627:therapeutic use; D013154:Spleen / Q000469:parasitology
D001600:Berberine Alkaloids; D001599:Berberine; D010419:Pentamidine; D004247:DNA